Evidence map›Paper›PMID 41699658›Full record

ArticleCell communication and signaling : CCS2026

Ep300-mediated acetylation plasticity in the acetyl-CoA metabolic network drives the protective role of intensive lifestyle intervention in visceral white adipose tissue.

Haojie Wu, Ying Lin, Xiaodong Sun, Ting Zhang, Hui Wang, Yubing Zeng, Yaqi Li, Shan Wang, Lin Shi

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haojie Wu *Department of Cardiovascular, Capital Center for Children's Health, Capital Medical University, Beijing, China.
Ying Lin *Department of Cardiovascular, Capital Center for Children's Health, Capital Medical University, Beijing, China.
Xiaodong SunDepartment of Cardiovascular, Capital Center for Children's Health, Capital Medical University, Beijing, China.
Ting ZhangBeijing Municipal Key Laboratory of Child Development and Nutriomics, Capital Institute of Pediatrics, Beijing, China.
Hui WangDepartment of Cardiovascular, Capital Center for Children's Health, Capital Medical University, Beijing, China.
Yubing ZengCapital Institute of Pediatrics, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Yaqi LiDepartment of Cardiovascular, Capital Center for Children's Health, Capital Medical University, Beijing, China.
Shan WangCapital Institute of Pediatrics, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. wsaquarius@sina.com.
Lin ShiDepartment of Cardiovascular, Capital Center for Children's Health, Capital Medical University, Beijing, China. shilin9789@126.com.

Funding

Capital's Funds for Health Improvement and Research CFH2022-3-2105New Quality Foundation of Capital Institute of Pediatrics XZYB-04New Quality Foundation of Capital Institute of Pediatrics XZYB-2025-01Public service development and reform pilot project of Beijing Medical Research Institute BMR2021-3The National Natural Science Foundation of China 82271193The Special Fund of Beijing Municipal Science & Technology Commission Z211100002921035
6 · The paper itself

Abstract

backgroundObesity is a major global health concern and a key driver of metabolic disorders. Intensive lifestyle intervention (ILI), combining caloric restriction and exercise, effectively promotes weight loss and improves metabolic health. Visceral white adipose tissue (vWAT) displays remarkable metabolic plasticity during weight fluctuation, yet the molecular mechanisms underlying ILI-induced remodeling remain unclear.

methodsWe developed a mouse model to simulate weight fluctuations induced by high-fat diet (HFD) followed by weight loss through ILI. Multi-omics data (proteomics, acetylomics, transcriptomics, and ChIP-seq) were collected from vWAT to investigate acetylation changes and metabolic reprogramming. Adeno-associated virus (AAV) and lentivirus vectors were employed to suppress Ep300 expression in vWAT, followed by an analysis of the effects on lipid accumulation, body weight, and overall metabolic health.

resultsEp300 expression was elevated under HFD and decreased after ILI, paralleling global changes in acetylation. Multi-omics integration revealed that acetyl-CoA metabolic network, encompassing glycolysis, the tricarboxylic acid (TCA) cycle, and fatty acid metabolism, was identified as a central hub regulated by Ep300. H3K36ac emerged as a key histone acetylation mark associated with nutritional states and Ep300 activity. Ep300 knockdown through AAV and lentivirus reproduced several metabolic benefits of ILI, including reduced lipid accumulation and body weight. Depot-specific responses were observed. Multi-omics integration in vWAT after Ep300 knockdown suggested that Ep300-mediated acetylation network in adipose tissue exerts an effect similar to ILI in reducing lipid accumulation, while positioning mitochondria as a crucial functional compartment within this regulatory network.

conclusionsThese findings suggest that Ep300-mediated acetylation plasticity contributes to the adaptive remodeling of vWAT during weight loss. By linking acetyl-CoA metabolism with mitochondrial function, Ep300 may serve as an epigenetic regulator coordinating metabolic flexibility during lifestyle intervention. These findings provide mechanistic insight into how lifestyle intervention reprograms adipose tissue and highlight the epigenetic flexibility underlying metabolic recovery after obesity.

Indexed as

Acetyl Coenzyme AAdipose Tissue, WhiteE1A-Associated p300 ProteinIntra-Abdominal FatLife StyleMetabolic Networks and PathwaysAcetylationAnimalsDiet, High-FatMaleMiceMice, Inbred C57BLObesityAcetyl Coenzyme AE1A-Associated p300 ProteinEp300 protein, mouseAcetylationEp300Intensive lifestyle interventionVisceral obese

Identifiers

PMID41699658
PMCPMC12937519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.